1. RETREATMENT WITH NIVOLUMAB IN PATIENTS WITH R/R CLASSICAL HODGKIN LYMPHOMA AFTER DISCONTINUATION OF THE THERAPY WITH IMMUNE CHECKPOINT INHIBITORS. (12th June 2019) Authors: Fedorova, L.; Lepik, K.; Mikhailova, N.; Kondakova, E.; Zalyalov, Y.; Baykov, V.; Babenko, E.; Borzenkova, E.; Tsvetkova, L.; Stelmakh, L.; Afanasyev, B. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 496 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗